GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OTCPK:GNGBF) » Definitions » Net-Net Working Capital

GNGBF (Getinge AB) Net-Net Working Capital : $-7.09 (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Getinge AB Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Getinge AB's Net-Net Working Capital for the quarter that ended in Sep. 2024 was $-7.09.

The industry rank for Getinge AB's Net-Net Working Capital or its related term are showing as below:

GNGBF's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 6.565
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Getinge AB Net-Net Working Capital Historical Data

The historical data trend for Getinge AB's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Net-Net Working Capital Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.17 -5.12 -3.97 -3.27 -4.72

Getinge AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.14 -4.72 -4.72 -4.96 -7.09

Competitive Comparison of Getinge AB's Net-Net Working Capital

For the Medical Devices subindustry, Getinge AB's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Getinge AB's Price-to-Net-Net-Working-Capital falls into.



Getinge AB Net-Net Working Capital Calculation

Getinge AB's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(265.949+0.75 * 559.488+0.5 * 625.487-2260.08
-0-23.105)/272.37
=-4.72

Getinge AB's Net-Net Working Capital (NNWC) per share for the quarter that ended in Sep. 2024 is calculated as

Net-Net Working Capital(Q: Sep. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(219.083+0.75 * 458.989+0.5 * 709.551-2849.448
-0-0)/272.37
=-7.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Getinge AB  (OTCPK:GNGBF) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Getinge AB Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Getinge AB's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

From GuruFocus

Q2 2023 Getinge AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Getinge AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2024 Getinge AB Earnings Call Transcript

By GuruFocus News 10-19-2024

Q1 2024 Getinge AB Earnings Call Transcript

By GuruFocus Research 04-23-2024

Q2 2021 Getinge AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2024 Getinge AB Earnings Call Transcript

By GuruFocus Research 07-19-2024

Q4 2022 Getinge AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Getinge AB Earnings Call Transcript

By GuruFocus Research 02-13-2024